Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
Authors:
Top Cited Papers
Open Access
- 8 March 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 14 (1) , 1-12
Abstract
Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policies and regulatory systems, a lack of competent regulatory professionals in National Medicines Regulatory Authorities (NMRAs) and ineffective regional collaborations among NMRAs. In response to national regulatory challenges in Africa, a number of regional harmonisation efforts were introduced through the African Medicines Regulatory Harmonisation (AMRH) initiative to, among others, expedite market authorisation of medical products and to facilitate the alignment of national legislative frameworks with the AU Model Law on Medical Products Regulation. The goals of the model law include to increase collaboration across countries and to facilitate the overall regional harmonisation process. The AMRH initiative is proposed to serve as the foundation for the establishment of the African Medicines Agency (AMA). The AMA will, as one of its mandates, coordinate the regional harmonisation systems that are enabled by AU Model Law domestication and implementation. In this paper, we review the key entities involved in regional and continental harmonisation of medicines regulation, the milestones achieved in establishing the AMA as well as the implementation targets and anticipated challenges related to the AU Model Law domestication and the AMA’s establishment. This review shows that implementation targets for the AU Model Law have not been fully met, and the AMA treaty has not been ratified by the minimum required number of countries for its establishment. In spite of the challenges, the AU Model Law and the AMA hold promise to address gaps and inconsistencies in national regulatory legislation as well as to ensure effective medicines regulation by galvanising technical support, regulatory expertise and resources at a continental level. Furthermore, this review provides recommendations for future research.Keywords
This publication has 17 references indexed in Scilit:
- Health ministers adopt African Medicines Agency treatyThe Lancet, 2018
- Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processesVaccine, 2018
- The African Medicines Regulatory Harmonization Initiative: Progress to DateMedical Research Archives, 2018
- Medicines Regulation in Africa: Current State and OpportunitiesPharmaceutical Medicine, 2017
- Towards African Medicines Regulatory Harmonization: The case of the East African CommunityPharmaceuticals Policy and Law, 2016
- Accelerating patient access to medicines in the Economic Community of West African States, the Southern African Development Community and the organization for the coordination of the fight against endemic diseasesPharmaceuticals Policy and Law, 2016
- The need for global regulatory harmonization: A public health imperativeScience Translational Medicine, 2016
- Strengthening Medical Product Regulation in Low- and Middle-Income CountriesPLOS Medicine, 2012
- Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa2012
- The African Medicines Regulatory Harmonization Initiative: Rationale and BenefitsClinical Pharmacology & Therapeutics, 2011